Molecular mechanisms of natural killer cell activation

Journal of Innate Immunity

Volumn 3, Issue 3, 2011, Pages 216-226

  Bryceson, Yenan T ^a   Chiang, Samuel C C ^a   Darmanin, Stephanie ^a   Fauriat, Cyril ^b   Schlums, Heinrich ^a   Theorell, Jakob ^a   Wood, Stephanie M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

c Cbl; Munc13 4; Natural killer cells; Perforin; VAV1; Wiskott Aldrich syndrome protein

Indexed keywords

CALCIUM BINDING PROTEIN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD16 ANTIGEN; CD56 ANTIGEN; CD59 ANTIGEN; CD7 ANTIGEN; CRK LIKE PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HERMES ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; STROMAL INTERACTION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 5;

CELL ACTIVATION; CELL ADHESION; CELL CONTACT; CELL MATURATION; EXOCYTOSIS; HUMAN; IMMUNE RESPONSE; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL COMMUNICATION; CYTOKINES; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTORS, NATURAL KILLER CELL; SIGNAL TRANSDUCTION;

EID: 79955107936     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000325265     Document Type: Review

References (86)

1. Bryceson YT, Long EO: Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol 2008; 20: 344-352.
2. Lanier LL: Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008; 9: 495-502. (Pubitemid 351560518)
3. Biron CA: More things in heaven and earth: defining innate and adaptive immunity. Nat Immunol 2010; 11: 1080-1082.
4. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S: Functions of natural killer cells. Nat Immunol 2008; 9: 503-510. (Pubitemid 351560519)
5. Flodstrom-Tullberg M, Bryceson YT, Shi FD, Hoglund P, Ljunggren HG: Natural killer cells in human autoimmunity. Curr Opin Immunol 2009; 21: 634-640.
6. von Bubnoff D, Andres E, Hentges F, Bieber T, Michel T, Zimmer J: Natural killer cells in atopic and autoimmune diseases of the skin. J Allergy Clin Immunol 2010; 125: 60-68.
7. Lodoen MB, Lanier LL: Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 2006; 18: 391-398. (Pubitemid 43947576)
8. Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ: Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2010, Epub ahead of print.
9. Ferlazzo G, Munz C: Dendritic cell interactions with NK cells from different tissues. J Clin Immunol 2009; 29: 265-273.
10. Malmberg KJ, Bryceson YT, Carlsten M, Andersson S, Bjorklund A, Bjorkstrom NK, Baumann BC, Fauriat C, Alici E, Dilber MS, Ljunggren HG: NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy. Cancer Immunol Immunother 2008; 57: 1541-1552.
11. Dustin ML, Long EO: Cytotoxic immunological synapses. Immunol Rev 2010; 235: 24-34.
12. Griffiths GM, Tsun A, Stinchcombe JC: The immunological synapse: a focal point for endocytosis and exocytosis. J Cell Biol 2010; 189: 399-406.
13. Wulfing C, Purtic B, Klem J, Schatzle JD: Stepwise cytoskeletal polarization as a series of checkpoints in innate but not adaptive cytolytic killing. Proc Natl Acad Sci USA 2003; 100: 7767-7772. (Pubitemid 36760044)
14. Deguine J, Breart B, Lemaitre F, Di Santo JP, Bousso P: Intravital imaging reveals distinct dynamics for natural killer and CD8(+) T cells during tumor regression. Immunity 2010; 33: 632-644.
15. Bryceson YT, March ME, Barber DF, Ljunggren HG, Long EO: Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 2005; 202: 1001-1012. (Pubitemid 41396899)
16. Bryceson YT, Ljunggren HG, Long EO: Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 2009; 114: 2657-2666.
17. Fauriat C, Long EO, Ljunggren HG, Bryceson YT: Regulation of human NK cell cytokine and chemokine production by target cell recognition. Blood 2010; 115: 2167-2176.
18. Bjorkstrom NK, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson MA, Bjorklund AT, Flodstrom-Tullberg M, Michaelsson J, Rottenberg ME, Guzman CA, Ljunggren HG, Malmberg KJ: Expression patterns of NKG2A, KIR, and CD57 define a process of CD56 dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010; 116: 3853-3864.
19. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagne F, Ugolini S, Vivier E: Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006; 25: 331-342. (Pubitemid 44224147)
20. Juelke K, Killig M, Luetke-Eversloh M, Parente E, Gruen J, Morandi B, Ferlazzo G, Thiel A, Schmitt-Knosalla I, Romagnani C: CD62L expression identifies a unique subset of polyfunctional CD56 dim NK cells. Blood 2010; 116: 1299-1307.
21. Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, Norris PJ, Nixon DF, Lanier LL: CD57 defines a functionally distinct population of mature NK cells in the human CD56 dim CD16 + NK-cell subset. Blood 2010; 116: 3865-3874.
22. Bryceson YT, Rudd E, Zheng C, Edner J, Ma D, Wood SM, Bechensteen AG, Boelens JJ, Celkan T, Farah RA, Hultenby K, Winiarski J, Roche PA, Nordenskjold M, Henter JI, Long EO, Ljunggren HG: Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 2007; 110: 1906-1915. (Pubitemid 47443904)
23. Bryceson YT, March ME, Ljunggren HG, Long EO: Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 2006; 214: 73-91. (Pubitemid 44707903)
24. Watzl C, Long EO: Signal transduction during activation and inhibition of natural killer cells. Curr Protoc Immunol 2010;Chapter 11:Unit 11.9B.
25. Long EO: Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev 2008; 224: 70-84.
26. Peterson ME, Long EO: Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity 2008; 29: 578-588.
27. Ting AT, Dick CJ, Schoon RA, Karnitz LM, Abraham RT, Leibson PJ: Interaction between lck and syk family tyrosine kinases in Fc gamma receptor-initiated activation of natural killer cells. J Biol Chem 1995; 270: 16415-16421.
28. Bryceson YT, March ME, Ljunggren HG, Long EO: Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006; 107: 159-166. (Pubitemid 43053538)
29. Tangye SG, Cherwinski H, Lanier LL, Phillips JH: 2B4-mediated activation of human natural killer cells. Mol Immunol 2000; 37: 493-501. (Pubitemid 32001691)
30. Eissmann P, Beauchamp L, Wooters J, Tilton JC, Long EO, Watzl C: Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 2005; 105: 4722-4729. (Pubitemid 40807295)
31. Veillette A: NK cell regulation by SLAM family receptors and SAP-related adapters. Immunol Rev 2006; 214: 22-34. (Pubitemid 44707899)
32. Parolini S, Bottino C, Falco M, Augugliaro R, Giliani S, Franceschini R, Ochs HD, Wolf H, Bonnefoy JY, Biassoni R, Moretta L, Notarangelo LD, Moretta A: X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virusinfected cells. J Exp Med 2000; 192: 337-346. (Pubitemid 30629159)
33. Shibuya A, Lanier LL, Phillips JH: Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. J Immunol 1998; 161: 1671-1676. (Pubitemid 28387583)
34. Upshaw JL, Arneson LN, Schoon RA, Dick CJ, Billadeau DD, Leibson PJ: NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol- 3-kinase in human natural killer cells. Nat Immunol 2006; 7: 524-532.
35. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, Walzer T: The trafficking of natural killer cells. Immunol Rev 2007; 220: 169-182. (Pubitemid 350045566)
36. Burshtyn DN, Shin J, Stebbins C, Long EO: Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Curr Biol 2000; 10: 777-780. (Pubitemid 30466940)
37. Barber DF, Long EO: Coexpression of CD58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells. J Immunol 2003; 170: 294-299. (Pubitemid 36026152)
38. Liu D, Bryceson YT, Meckel T, Vasiliver-Shamis G, Dustin ML, Long EO: Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. Immunity 2009; 31: 99-109.
39. Stebbins CC, Watzl C, Billadeau DD, Leibson PJ, Burshtyn DN, Long EO: Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol 2003; 23: 6291-6299. (Pubitemid 37013105)
40. Culley FJ, Johnson M, Evans JH, Kumar S, Crilly R, Casasbuenas J, Schnyder T, Mehrabi M, Deonarain MP, Ushakov DS, Braud V, Roth G, Brock R, Kohler K, Davis DM: Natural killer cell signal integration balances synapse symmetry and migration. PLoS Biol 2009; 7:e1000159.
41. Awasthi A, Samarakoon A, Chu H, Kamalakannan R, Quilliam LA, Chrzanowska- Wodnicka M, White II GC, Malarkannan S: Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes. J Exp Med 2010; 207: 1923-1938.
42. Mace EM, Monkley SJ, Critchley DR, Takei F: A dual role for talin in NK cell cytotoxicity: activation of LFA-1-mediated cell adhesion and polarization of NK cells. J Immunol 2009; 182: 948-956.
43. Stabile H, Carlino C, Mazza C, Giliani S, Morrone S, Notarangelo LD, Notarangelo LD, Santoni A, Gismondi A: Impaired NKcell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine- induced beta2 integrin high-affinity state. Blood 2010; 115: 2818-2826.
44. Segovis CM, Schoon RA, Dick CJ, Nacusi LP, Leibson PJ, Billadeau DD: PI3K links NKG2D signaling to a CrkL pathway involved in natural killer cell adhesion, polarity, and granule secretion. J Immunol 2009; 182: 6933-6942.
45. Butler B, Kastendieck DH, Cooper JA: Differently phosphorylated forms of the cortactin homolog HS1 mediate distinct functions in natural killer cells. Nat Immunol 2008; 9: 887-897.
46. Kinashi T: Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 2005; 5: 546-559. (Pubitemid 40961332)
47. Barber DF, Faure M, Long EO: LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol 2004; 173: 3653-3659. (Pubitemid 39280725)
48. Mentlik AN, Sanborn KB, Holzbaur EL, Orange JS: Rapid lytic granule convergence to the MTOC in natural killer cells is dependent on dynein but not cytolytic commitment. Mol Biol Cell 2010; 21: 2241-2256.
49. Stinchcombe JC, Majorovits E, Bossi G, Fuller S, Griffiths GM: Centrosome polarization delivers secretory granules to the immunological synapse. Nature 2006; 443: 462-465. (Pubitemid 44477283)
50. Mace EM, Zhang J, Siminovitch KA, Takei F: Elucidation of the integrin LFA-1-mediated signaling pathway of actin polarization in natural killer cells. Blood 2010; 116: 1272-1279.
51. Micucci F, Capuano C, Marchetti E, Piccoli M, Frati L, Santoni A, Galandrini R: PI5KIdependent signals are critical regulators of the cytolytic secretory pathway. Blood 2008; 111: 4165-4172.
52. Krzewski K, Chen X, Strominger JL: WIP is essential for lytic granule polarization and NK cell cytotoxicity. Proc Natl Acad Sci USA 2008; 105: 2568-2573. (Pubitemid 351520554)
53. Quann EJ, Merino E, Furuta T, Huse M: Localized diacylglycerol drives the polarization of the microtubule-organizing center in T cells. Nat Immunol 2009; 10: 627-635.
54. March ME, Long EO: Beta2 integrin induces TCRz-Syk-phospholipase C-gamma phosphorylation and paxillin-dependent granule polarization in human NK cells. J Immunol 2011; 186: 2998-3005.
55. Meng X, Kanwar N, Du Q, Goping IS, Bleackley RC, Wilkins JA: PPP1R9B (neurabin 2): involvement and dynamics in the NK immunological synapse. Eur J Immunol 2009; 39: 552-560.
56. Sancho D, Nieto M, Llano M, Rodriguez- Fernandez JL, Tejedor R, Avraham S, Cabanas C, Lopez-Botet M, Sanchez-Madrid F: The tyrosine kinase PYK-2/RAFTK regulates natural killer (NK) cell cytotoxic response, and is translocated and activated upon specific target cell recognition and killing. J Cell Biol 2000; 149: 1249-1262.
57. Li C, Ge B, Nicotra M, Stern JN, Kopcow HD, Chen X, Strominger JL: JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity. Proc Natl Acad Sci USA 2008; 105: 3017-3022. (Pubitemid 351723660)
58. Butler B, Cooper JA: Distinct roles for the actin nucleators Arp2/3 and hDia1 during NKmediated cytotoxicity. Curr Biol 2009; 19: 1886-1896.
59. Jiang K, Zhong B, Gilvary DL, Corliss BC, Hong-Geller E, Wei S, Djeu JY: Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat Immunol 2000; 1: 419-425.
60. Caraux A, Kim N, Bell SE, Zompi S, Ranson T, Lesjean-Pottier S, Garcia-Ojeda ME, Turner M, Colucci F: Phospholipase C-gamma2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood 2006; 107: 994-1002. (Pubitemid 43156297)
61. Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M: Phospholipase C- {gamma}2 is a critical signaling mediator for murine NK cell activating receptors. J Immunol 2005; 175: 749-754. (Pubitemid 41094955)
62. Kim HS, Das A, Gross CC, Bryceson YT, Long EO: Synergistic signals for natural cytotoxicity are required to overcome' inhibition by c-Cbl ubiquitin ligase. Immunity 2010; 32: 175-186.
63. Maul-Pavicic A, Chiang SCC, Rensing-Ehl A, Jessen B, Fauriat C, Wood SM, Sjöqvist S, Hufnagel M, Schulze I, Bass T, Schamel WWA, Fuchs S, Pircher H, McCarl C-A, Mikoshiba K, Schwarz K, Feske S, Bryceson YT, Ehl S: ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis. Proc Natl Acad Sci USA 2011;108:3324-3329.
64. Sudhof TC, Rothman JE: Membrane fusion: grappling with SNARE and SM proteins. Science 2009; 323: 474-477.
65. de Saint Basile G, Menasche G, Fischer A: Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol 2010; 10: 568-579.
66. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, Lambert N, Ouachee- Chardin M, Chedeville G, Tamary H, Minard- Colin V, Vilmer E, Blanche S, Le Deist F, Fischer A, de Saint Basile G: Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003; 115: 461-473. (Pubitemid 37456808)
67. Marcenaro S, Gallo F, Martini S, Santoro A, Griffiths GM, Arico M, Moretta L, Pende D: Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood 2006; 108: 2316-2323. (Pubitemid 44497515)
68. Cote M, Menager MM, Burgess A, Mahlaoui N, Picard C, Schaffner C, Al-Manjomi F, Al- Harbi M, Alangari A, Le Deist F, Gennery AR, Prince N, Cariou A, Nitschke P, Blank U, El-Ghazali G, Menasche G, Latour S, Fischer A, de Saint Basile G: Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest 2009; 119: 3765-3773.
69. zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, Strauss J, Kasper B, Nurnberg G, Becker C, Maul-Pavicic A, Beutel K, Janka G, Griffiths G, Ehl S, Hennies HC: Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet 2009; 85: 482-492.
70. Meeths M, Entesarian M, Al-Herz W, Chiang SC, Wood SM, Al-Ateeqi W, Almazan F, Boelens JJ, Hasle H, Ifversen M, Lund B, van den Berg JM, Gustafsson B, Hjelmqvist H, Nordenskjold M, Bryceson YT, Henter JI: Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis (FHL) type 5 patients with mutations in STXBP2. Blood 2010; 116: 2635-2643.
71. Stinchcombe JC, Barral DC, Mules EH, Booth S, Hume AN, Machesky LM, Seabra MC, Griffiths GM: Rab27a is required for regulated secretion in cytotoxic T lymphocytes. J Cell Biol 2001; 152: 825-834.
72. Menasche G, Menager MM, Lefebvre JM, Deutsch E, Athman R, Lambert N, Mahlaoui N, Court M, Garin J, Fischer A, de Saint Basile G: A newly identified isoform of Slp2a associates with Rab27a in cytotoxic T cells and participates to cytotoxic granule secretion. Blood 2008; 112: 5052-5062.
73. Holt O, Kanno E, Bossi G, Booth S, Daniele T, Santoro A, Arico M, Saegusa C, Fukuda M, Griffiths GM: Slp1 and Slp2-a localize to the plasma membrane of CTL and contribute to secretion from the immunological synapse. Traffic 2008; 9: 446-457. (Pubitemid 351351607)
74. Menager MM, Menasche G, Romao M, Knapnougel P, Ho CH, Garfa M, Raposo G, Feldmann J, Fischer A, de Saint Basile G: Secretory cytotoxic granule maturation and exocytosis require the effector protein hMunc13-4. Nat Immunol 2007; 8: 257-267. (Pubitemid 46745375)
75. Wood SM, Meeths M, Chiang SC, Bechensteen AG, Boelens JJ, Heilmann C, Horiuchi H, Rosthoj S, Rutynowska O, Winiarski J, Stow JL, Nordenskjold M, Henter JI, Ljunggren HG, Bryceson YT: Different NK cellactivating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity. Blood 2009; 114: 4117-4127.
76. Lee SH, Yun S, Lee J, Kim MJ, Piao ZH, Jeong M, Chung JW, Kim TD, Yoon SR, Greenberg PD, Choi I: RasGRP1 is required for human NK cell function. J Immunol 2009; 183: 7931-7938.
77. Giurisato E, Lin J, Harding A, Cerutti E, Cella M, Lewis RE, Colonna M, Shaw AS: The mitogen-activated protein kinase scaffold KSR1 is required for recruitment of extracellular signal-regulated kinase to the immunological synapse. Mol Cell Biol 2009; 29: 1554-1564.
78. Sanborn KB, Rak GD, Maru SY, Demers K, Difeo A, Martignetti JA, Betts MR, Favier R, Banerjee PP, Orange JS: Myosin IIA associates with NK cell lytic granules to enable their interaction with F-actin and function at the immunological synapse. J Immunol 2009; 182: 6969-6984.
79. Kim N, Saudemont A, Webb L, Camps M, Ruckle T, Hirsch E, Turner M, Colucci F: The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion. Blood 2007; 110: 3202-3208. (Pubitemid 350106312)
80. Tassi I, Cella M, Gilfillan S, Turnbull I, Diacovo TG, Penninger JM, Colonna M: p110gamma and p110delta phosphoinositide 3-kinase signaling pathways synergize to control development and functions of murine NK cells. Immunity 2007; 27: 214-227. (Pubitemid 47284932)
81. Tassi I, Cella M, Presti R, Colucci A, Gilfillan S, Littman DR, Colonna M: NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion. Blood 2008; 112: 4109-4116.
82. Arneson LN, Segovis CM, Gomez TS, Schoon RA, Dick CJ, Lou Z, Billadeau DD, Leibson PJ: Dynamin 2 regulates granule exocytosis during NK cell-mediated cytotoxicity. J Immunol 2008; 181: 6995-7001.
83. Davis DM: Mechanisms and functions for the duration of intercellular contacts made by lymphocytes. Nat Rev Immunol 2009; 9: 543-555.
84. Rudd E, Bryceson YT, Zheng C, Edner J, Wood SM, Ramme K, Gavhed S, Gurgey A, Hellebostad M, Bechensteen A, Ljunggren HG, Fadeel B, Nordenskjold M, Henter JI: Spectrum, and clinical and functional implications of UNC13D mutations in familial hemophagocytic lymphohistiocytosis. J Med Genet 2008; 45: 134-141. (Pubitemid 351373741)
85. Gismondi A, Cifaldi L, Mazza C, Giliani S, Parolini S, Morrone S, Jacobelli J, Bandiera E, Notarangelo L, Santoni A: Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood 2004; 104: 436-443. (Pubitemid 38900026)
86. Lee SH, Yun S, Piao ZH, Jeong M, Kim DO, Jung H, Lee J, Kim MJ, Kim MS, Chung JW, Kim TD, Yoon SR, Greenberg PD, Choi I: Suppressor of cytokine signaling 2 regulates IL-15-primed human NK cell function via control of phosphorylated Pyk2. J Immunol 2010; 185: 917-928.